From NAFLD to MASLD: Promise and pitfalls of a new definition †

Kenneth Cusi¹, Zobair Younossi², Michael Roden^{3

4}

Affiliations

¹ Division of Endocrinology, Diabetes and Metabolism The University of Florida, Gainesville, FL, USA.
² Global NASH Council Center for Outcomes Research in Liver Diseases, Washington DC, USA.
³ Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, Düsseldorf, Germany.
⁴ Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Kenneth Cusi et al. Hepatology. 2024.

. 2024 Feb 1;79(2):E13-E15.

doi: 10.1097/HEP.0000000000000706. Epub 2023 Dec 19.

Kenneth Cusi¹, Zobair Younossi², Michael Roden^{3

4}

¹ Division of Endocrinology, Diabetes and Metabolism The University of Florida, Gainesville, FL, USA.
² Global NASH Council Center for Outcomes Research in Liver Diseases, Washington DC, USA.
³ Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, Düsseldorf, Germany.
⁴ Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

No abstract available

References

1. Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022;76:1423–1437.
1. Ciardullo S, Carbone M, Invernizzi P, Perseghin G, et al. Exploring the landscape of steatotic liver disease in the general US population. Liver Int. 2023;43:2425–2433.
1. Song SJ, Lai JC, Wong GL, Wong VW, Yip TC, et al. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2023;S0168-8278:05000–05006.
1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care. 2005;28:1769–1778.
1. Simmons RK, Alberti KGMM, Gale EAM, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: Useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53:600–605.